A New Approach to Hepatitis C Treatment: Keep It Simple & Safe A multinational, NIAID-funded study has revealed that a "minimal monitoring" approach to delivering hepatitis C treatment is safe and results in similarly high cure rates as standard approaches. Hepatitis C treatment programs typically involve frequent laboratory and clinical monitoring, making them challenging to optimally implement in resource-limited areas. The study, involving 400 participants in five countries on four continents, evaluated a treatment delivery approach that minimizes in-person clinic appointments and laboratory tests during 12 weeks of treatment with antiviral drugs. This approach safely achieved a 95% hepatitis C cure rate among study participants, researchers reported at The Liver Meeting Digital Experience (TLMdx). National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107